5 AM Ventures
| San Francisco 3000 Sand Hill Road Building 4, Suite Menlo Park, CA 94025 (650)-233-8600 |
Boston 950 Winter Street 230 Suite 4510 Waltham, MA 02451 (781)-890-4480 |
 |
||
| 5AM website |
Background
5AM Ventures was founded in 2002 with the launch of its first Fund, 5AM Ventures, L.P. The firm has approximately $215million under management and invests primarily in seed and early-stages of life science companies.
Key Contacts
- John Diekman, PhD. (Founder and Managing Partner): Prior to founding 5 AM Ventures, Dr. Diekman was a Founder, Managing Director and Vice Chairman at Bay City Capital, a life science investment firm. Dr. Diekman has over 30 years of experience in the life science industry and currently serves on the Boards of Affymetrix, Ambrx, Antipodean, Ingenuity Systems, Phenomix, S*BIO, and the California Institute of Technology. Dr. Diekman has received a PhD from Stanford University. Contact information (San Francisco office): john@5amventures.com
- Scott Rocklage, PhD. (Managing Partner): Dr. Rocklage joined 5AM Ventures in 2003 and possesses over 20 years of healthcare management experience. He currently serves as Board Chairman of Achaogen and Ilypsa and is also on the Boards of Pulmatrix, WaveRx, and the Board of Associates at the Whitehead Institute. Dr. Rocklage has received a PhD from the Massachusetts Institute of Technology. Contact information (Boston office): scott@5amventures.com
- Andrew Schwab (Founder and Managing Partner): Prior to founding 5 AM Ventures, Mr. Schwab was a Principal at Bay City Capital. He currently serves on the Board of Directors of Ikaria, Panomics, and Synosis Therapeutics and is a member of the Cincinnati Children's Hospital Technology Validation Advisory Board. Mr. Schwab has received a B.S. with honors from Davidson College. Contact information (San Francisco office): andy@5amventures.com
Top Co-Investors
Delphi Ventures, Frazier Healthcare, Polaris Ventures, Three Arch Partners, Venrock Associates, Versant Ventures.
<< Back to Portfolio list
